Find a copy online
Links to this item
Find a copy in the library
Finding libraries that hold this item...
|Additional Physical Format:||Print version:
Institute of Medicine (U.S.). Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute.
Washington, D.C. : National Academy Press, 1991
|Material Type:||Document, Internet resource|
|Document Type:||Internet Resource, Computer File|
|All Authors / Contributors:||
John R Hogness; Malin VanAntwerp; Institute of Medicine (U.S.). Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute.; National Heart, Lung, and Blood Institute.
|Notes:||"Support for this project was provided by the National Institutes of Health, National Heart, Lung, and Blood Institute, pursuant to contract no. NO1-HO-09008"--Title page verso.|
|Reproduction Notes:||Electronic reproduction. [S.l.] : HathiTrust Digital Library, 2010. MiAaHDL|
|Description:||1 online resource (xii, 298 pages) : illustrations|
|Details:||Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.|
|Contents:||1 Front Matter; 2 Executive Summary; 3 1. The Artificial Heart Program: Current Status and History; 4 2. Total Artificial Hearts: Technological Potential and Research and Development Costs; 5 3. Decisions for Future Research and Development; 6 4. Clinical Effectiveness and Need for Long-Term Circulatory Support; 7 5. Quality of Life and Mechanical Circulatory Support Systems; 8 6. Cost-Effectiveness Analysis; 9 7. The Appropriate Use of Technology; 10 8. Ethical and Societal Issues; 11 9. Roles of Government and Industry in Medical Technology Research, Development and Use; 12 10. Conclusions and Recommendations; 13 Appendix A: History and Methods of This Evaluation; 14 Appendix B: A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events; 15 Appendix C: Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems; 16 Appendix D: Epidemiology of End-Stage Heart Disease; 17 Appendix E: Assessing the Cost-Effectiveness of the Development and Use of the Total Artificial Heart; 18 Glossary; 19 Index|
|Responsibility:||Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute, Division of Health Care Services, Institute of Medicine ; John R. Hogness and Malin VanAntwerp, editors.|